• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院感染及其抗生素耐药的分子机制。

Nosocomial infection and its molecular mechanisms of antibiotic resistance.

作者信息

Xia Jufeng, Gao Jianjun, Tang Wei

机构信息

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo.

出版信息

Biosci Trends. 2016 Feb;10(1):14-21. doi: 10.5582/bst.2016.01020. Epub 2016 Feb 11.

DOI:10.5582/bst.2016.01020
PMID:26877142
Abstract

Nosocomial infection is a kind of infection, which is spread in various hospital environments, and leads to many serious diseases (e.g. pneumonia, urinary tract infection, gastroenteritis, and puerperal fever), and causes higher mortality than community-acquired infection. Bacteria are predominant among all the nosocomial infection-associated pathogens, thus a large number of antibiotics, such as aminoglycosides, penicillins, cephalosporins, and carbapenems, are adopted in clinical treatment. However, in recent years antibiotic resistance quickly spreads worldwide and causes a critical threat to public health. The predominant bacteria include Methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Acinetobacter baumannii. In these bacteria, resistance emerged from antibiotic resistant genes and many of those can be exchanged between bacteria. With technical advances, molecular mechanisms of resistance have been gradually unveiled. In this review, recent advances in knowledge about mechanisms by which (i) bacteria hydrolyze antibiotics (e.g. extended spectrum β-lactamases, (ii) AmpC β-lactamases, carbapenemases), (iii) avoid antibiotic targeting (e.g. mutated vanA and mecA genes), (iv) prevent antibiotic permeation (e.g. porin deficiency), or (v) excrete intracellular antibiotics (e.g. active efflux pump) are summarized.

摘要

医院感染是一种在各种医院环境中传播的感染,可导致许多严重疾病(如肺炎、尿路感染、肠胃炎和产褥热),并且其死亡率高于社区获得性感染。在所有与医院感染相关的病原体中,细菌占主导地位,因此临床治疗中采用了大量抗生素,如氨基糖苷类、青霉素类、头孢菌素类和碳青霉烯类。然而,近年来抗生素耐药性在全球迅速传播,对公众健康构成严重威胁。主要的细菌包括耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌、肺炎克雷伯菌、大肠埃希菌和鲍曼不动杆菌。在这些细菌中,耐药性源于抗生素耐药基因,其中许多基因可在细菌之间交换。随着技术进步,耐药的分子机制已逐渐被揭示。在本综述中,总结了关于细菌(i)水解抗生素(如超广谱β-内酰胺酶)、(ii)AmpCβ-内酰胺酶、碳青霉烯酶、(iii)避免抗生素靶向(如vanA和mecA基因突变)、(iv)阻止抗生素渗透(如孔蛋白缺乏)或(v)排出细胞内抗生素(如主动外排泵)的机制的最新研究进展。

相似文献

1
Nosocomial infection and its molecular mechanisms of antibiotic resistance.医院感染及其抗生素耐药的分子机制。
Biosci Trends. 2016 Feb;10(1):14-21. doi: 10.5582/bst.2016.01020. Epub 2016 Feb 11.
2
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.革兰氏阴性细菌病原体对头孢菌素类和碳青霉烯类的耐药性。
Int J Med Microbiol. 2010 Aug;300(6):371-9. doi: 10.1016/j.ijmm.2010.04.005. Epub 2010 May 27.
3
[Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].[2005年至2009年期间,贝鲁特一家大学医院中心大肠杆菌、肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌对抗生素敏感性的演变]
Pathol Biol (Paris). 2012 Jun;60(3):e15-20. doi: 10.1016/j.patbio.2011.03.011. Epub 2011 Jun 29.
4
[Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].[产碳青霉烯酶肠杆菌科细菌引起的感染性疾病——抗菌治疗面临的特殊挑战]
Med Monatsschr Pharm. 2014 May;37(5):162-72; quiz 173-4.
5
[Monitoring and antibiotic resistance profile of tracheal aspirate microbiota in ICU children with severe craniocerebral trauma].[重症颅脑外伤重症监护病房儿童气管吸出物微生物群的监测及抗生素耐药谱]
Antibiot Khimioter. 2014;59(7-8):8-15.
6
Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.重症监护病房中多重耐药革兰氏阴性杆菌的趋势及延长β-内酰胺类药物输注时间的作用。
Crit Care Nurs Q. 2013 Oct-Dec;36(4):345-55. doi: 10.1097/CNQ.0b013e3182a10d2f.
7
[Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres].[革兰氏阴性菌中的碳青霉烯酶。国家参考中心工作产生的耐药性现状与趋势]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1401-4. doi: 10.1007/s00103-012-1552-x.
8
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].[土耳其医院革兰氏阴性医院分离株对新型β-内酰胺类及相关超广谱β-内酰胺酶类型的耐药性:多中心HITIT研究结果]
Mikrobiyol Bul. 2008 Oct;42(4):537-44.
9
[The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].[临床相关革兰氏阴性菌中日益严重的抗生素耐药性问题:现状]
Enferm Infecc Microbiol Clin. 2010 Sep;28 Suppl 2:25-31. doi: 10.1016/S0213-005X(10)70027-6.
10
ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014.免疫抑制患者严重全身感染分离菌株的病因及耐药情况——雅西传染病医院2011 - 2014年经验
Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1141-6.

引用本文的文献

1
Anti-bacterial activity of dermcidin in human platelets: suppression of methicillin-resistant growth.人血小板中防御素的抗菌活性:抑制耐甲氧西林菌生长。
Microbiol Spectr. 2025 Jul;13(7):e0327324. doi: 10.1128/spectrum.03273-24. Epub 2025 May 27.
2
Exploring the evolution of and resistance during the COVID-19 era.探索新冠疫情期间(病毒的)进化及耐药性。 (注:原文中“and”前缺少具体内容,根据语境补充了“病毒的”,以使译文更通顺)
Antimicrob Steward Healthc Epidemiol. 2025 Mar 26;5(1):e88. doi: 10.1017/ash.2025.46. eCollection 2025.
3
Small-Molecule Probes: Recent Progress in the Rapid Detection of Carbapenemase-Producing Bacteria.
小分子探针:产碳青霉烯酶细菌快速检测的最新进展
Pharmaceutics. 2025 Feb 20;17(3):282. doi: 10.3390/pharmaceutics17030282.
4
Pathogens of Medical Importance Identified in Hospital-Collected Cockroaches: A Systematic Review.医院采集蟑螂中鉴定出的具有医学重要性的病原体:一项系统综述。
Microorganisms. 2025 Feb 4;13(2):337. doi: 10.3390/microorganisms13020337.
5
Characterization, Antibiotic Susceptibility, and Clonal Analysis of Carbapenem-Resistant Klebsiella pneumoniae From Different Clinical Cases.不同临床病例中耐碳青霉烯类肺炎克雷伯菌的特征分析、药敏试验及克隆分析
Cureus. 2024 Oct 19;16(10):e71889. doi: 10.7759/cureus.71889. eCollection 2024 Oct.
6
Trends and implications of antimicrobial resistance in Pseudomonas aeruginosa: Insights from a 19-year study in Zhejiang Province.铜绿假单胞菌的抗生素耐药趋势及意义:来自浙江省 19 年研究的新视角
Medicine (Baltimore). 2024 Nov 15;103(46):e40606. doi: 10.1097/MD.0000000000040606.
7
Healthcare-Associated Infections: Pre- and Post-pandemic Microbiological Profile and Antibiotic Resistance.医疗保健相关感染:大流行前和大流行后的微生物学特征及抗生素耐药性
Cureus. 2024 Sep 26;16(9):e70263. doi: 10.7759/cureus.70263. eCollection 2024 Sep.
8
Nosocomial, Healthcare-Associated, and Community-Acquired in China: Clinical Characteristics, Antimicrobial Resistance Patterns and Risk Factors Associated with Carbapenem Resistance.中国的医院获得性、医疗保健相关和社区获得性感染:临床特征、抗菌药物耐药模式及与碳青霉烯类耐药相关的危险因素
Infect Drug Resist. 2024 Sep 19;17:4089-4099. doi: 10.2147/IDR.S469244. eCollection 2024.
9
Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence.头孢他啶/他唑巴坦的应用视角:临床试验数据和真实世界证据的回顾。
Future Microbiol. 2024;19(6):465-480. doi: 10.2217/fmb-2023-0197. Epub 2024 Jan 22.
10
Metal nanoparticles as inhibitors of enzymes and toxins of multidrug-resistant .金属纳米颗粒作为多重耐药性酶和毒素的抑制剂
Infect Med (Beijing). 2023 Nov 21;2(4):294-307. doi: 10.1016/j.imj.2023.11.006. eCollection 2023 Dec.